Stock 300832 SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Shenzhen New Industries Biomedical Engineering Co., Ltd.

Equities

300832

CNE100003T39

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-21 pm EDT 		5-day change 1st Jan Change
64.88 CNY +0.31% Intraday chart for Shenzhen New Industries Biomedical Engineering Co., Ltd. -1.47% -17.03%
Apr. 18 Shenzhen New Industries Biomedical Engineering Gets Nod to Register Five Devices MT
Apr. 12 Shenzhen New Industries Biomedical Engineering's 2023 Profit Jumps 25% MT

Business Summary

Shenzhen New Industries Biomedical Engineering Co Ltd is a company engaged in research and development, production and sales of in-vitro diagnostics instruments and supporting reagents. The Company operates three segments, including Instruments and Supporting Software, Reagents, Accessories and Others. Instruments and Supporting Software segment is involved in the production and sales of MAGLUMI automatic chemiluminescence immunoassay analyzer series products and Biossays automatic biochemical analyzer series products. Reagents segment operates the sales of supporting reagents for the analyzers. The products are applied in the examination of Gonads, thyroid gland, glucose metabolism, kidney function and so on. Accessories and Others segment is responsible for the manufacturing and sales of accessories related to in-vitro diagnostics equipment. The Company sells its products both in domestic and international markets, including Asia, Europe, America and Africa.

Number of employees: 2,627

Sales per Business

CNY in Million2022Weight2023Weight Delta
Reagent
72.7 %
2,187 71.8 % 2,858 72.7 % +30.72%
Instrument
27.0 %
854 28.0 % 1,061 27.0 % +24.31%
Other Business
0.3 %
6 0.2 % 10 0.3 % +53.15%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
66.4 %
2,077 68.2 % 2,608 66.4 % +25.58%
Abroad
33.6 %
970 31.8 % 1,322 33.6 % +36.23%

Managers

Managers TitleAgeSince
Wei Rao CEO
 Chief Executive Officer 60 12-08-16
Chen Liu Ding DFI
 Director of Finance/CFO 49 04-09-30
Jie Ma BRD
 Director/Board Member 31 16-05-31
Yu Jie Li IRC
 Investor Relations Contact - -
Lei Zhang SEC
 Corporate Secretary 42 12-04-30

Members of the board

Members of the board TitleAgeSince
Qing Wei Zhang BRD
 Director/Board Member 49 12-07-31
Wei Rao CEO
 Chief Executive Officer 60 12-08-16
Dai Na Wang BRD
 Director/Board Member 61 18-09-09
Deng Ke Liu CHM
 Chairman 46 15-08-31
Jie Rao BRD
 Director/Board Member 35 11-03-10
Qian Hui Wu BRD
 Director/Board Member 51 22-05-11
He Ming Weng BRD
 Director/Board Member 26 21-09-07
Xin He BRD
 Director/Board Member 28 21-09-07
Jie Ma BRD
 Director/Board Member 31 16-05-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 785,718,785 309,759,168 ( 39.42 %) 0 39.42 %

Shareholders

NameEquities%Valuation
Xian Ding Weng
33.81 %
236,124,600 33.81 % 2 161 M ¥
Hongshan
16.45 %
114,880,000 16.45 % 1 051 M ¥
Wei Rao
3.873 %
27,051,250 3.873 % 248 M ¥
Jie Rao
3.589 %
25,066,700 3.589 % 229 M ¥
Aegon-Industrial Fund Management Co., Ltd.
2.262 %
15,800,599 2.262 % 145 M ¥
Fullgoal Fund Management Co., Ltd.
1.421 %
9,924,278 1.421 % 91 M ¥
Hwabao WP Fund Management Co., Ltd.
1.210 %
8,452,679 1.210 % 77 M ¥
Penghua Fund Management Co., Ltd.
0.8545 %
5,967,937 0.8545 % 55 M ¥
HuaAn Fund Management Co., Ltd.
0.7105 %
4,961,929 0.7105 % 45 M ¥
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)
0.5806 %
4,055,134 0.5806 % 37 M ¥
NameEquities%Valuation
Wei Rao
92.94 %
81,153,750 92.94 % 743 M ¥
Hai Yan Liu
1.068 %
932,587 1.068 % 9 M ¥
Lei Zhang
0.9889 %
863,500 0.9889 % 8 M ¥
Ting Hua Li
0.8055 %
703,400 0.8055 % 6 M ¥
Xiao Hong Zhang
0.1077 %
94,050 0.1077 % 860 672 ¥

Holdings

NameEquities%Valuation
ADICON HOLDINGS LIMITED
0.87%
 6,361,500 0.87% 9,753,833 $

Company contact information

Shenzhen New Industries Biomedical Engineering Co., Ltd.

New Industrial Biology Building 23 Jinxiu East Rd, Jinsha Community

518118, Shenzhen

+

http://www.snibe.com
address Shenzhen New Industries Biomedical Engineering Co., Ltd.(300832)

Sector

Healthcare
Healthcare Services
Healthcare Equipment & Supplies
Medical Equipment, Supplies & Distribution
Diagnostic & Testing Substances

Sales per Business

Sales per region

Ratings for Shenzhen New Industries Biomedical Engineering Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
64.88 CNY
Average target price
83.35 CNY
Spread / Average Target
+28.47%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

1st Jan change Capi.
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. Stock Shenzhen New Industries Biomedical Engineering Co., Ltd.
-17.03% 7.04B
BIOMÉRIEUX Stock bioMérieux
+0.89% 12.66B
DIASORIN S.P.A. Stock DiaSorin S.p.A.
+2.02% 5.39B
AUTOBIO DIAGNOSTICS CO., LTD. Stock Autobio Diagnostics Co., Ltd.
-2.51% 4.45B
LANTHEUS HOLDINGS, INC. Stock Lantheus Holdings, Inc.
+1.73% 4.32B
10X GENOMICS, INC. Stock 10x Genomics, Inc.
-50.32% 3.31B
ANDON HEALTH CO., LTD. Stock Andon Health Co., Ltd.
+6.90% 2.6B
VITROLIFE AB Stock Vitrolife AB
-17.00% 2.01B
MYRIAD GENETICS, INC. Stock Myriad Genetics, Inc.
-3.40% 1.67B
GUANGZHOU WONDFO BIOTECH CO.,LTD Stock Guangzhou Wondfo Biotech Co.,Ltd
-15.51% 1.65B
Diagnostic & Testing Substances
  1. Stock Market
  2. Equities
  3. 300832 Stock
  4. Company Shenzhen New Industries Biomedical Engineering Co., Ltd.